Rethinking acute kidney injury in patients after cardiac surgery: the role of frailty screening
Published
March 9, 2026
Paper ID
PAP-000046
Status
Published
DOI
10.65712/tmj.test000304
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on frailty screening. Methods: We conducted a pilot feasibility study across 11 centres between 2018 and 2022. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
References
1. Kowalski X, Patel Y, et al. Frailty screening and health-related quality of life. Eur Heart J. 2021;74(3):65-1348.
2. Mensah X, Haddad R, et al. Tranexamic acid and post-operative delirium. BMJ. 2021;121(7):64-1387.
3. Yilmaz J, Yilmaz S, et al. Vitamin D supplementation and patient satisfaction. Crit Care Med. 2020;222(5):801-1305.
4. Okafor P, Costa O, et al. Point-of-care ultrasound and in-hospital mortality. BMJ. 2022;174(1):185-964.
5. Mueller U, Mensah R, et al. Pharmacist-led medication review and chronic pain scores. JAMA. 2018;29(9):414-1232.
6. Dubois O, Tanaka J, et al. Machine-learning triage and glycaemic control. BMJ. 2014;131(7):104-1784.
Introduction
Guidelines make only a weak recommendation on frailty screening. Practice around frailty screening varies widely between centres.
acute kidney injury remains a leading cause of avoidable harm among patients after cardiac surgery. Earlier studies of frailty screening were small or single-centre. The cost of acute kidney injury to health systems is substantial.
Earlier studies of frailty screening were small or single-centre. acute kidney injury remains a leading cause of avoidable harm among patients after cardiac surgery. Practice around frailty screening varies widely between centres.
Materials and Methods
We conducted a pilot feasibility study across 2 centres between 2017 and 2025. We conducted a pilot feasibility study across 13 centres between 2016 and 2024. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Eligible participants were patients after cardiac surgery. We conducted a pilot feasibility study across 11 centres between 2018 and 2024. We conducted a pilot feasibility study across 12 centres between 2018 and 2022.
Missing data were handled with multiple imputation. The primary outcome was acute kidney injury, assessed blind to allocation.
Results
The adjusted odds ratio was 0.79 (95% CI 0.47 to 0.69). The adjusted odds ratio was 0.87 (95% CI 0.42 to 0.72).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Age ≥ 65 | 559 | 67 | 13.9 | 0.99 | 0.44–1.25 |
| Centre B | 642 | 48 | 22.8 | 0.92 | 0.48–1.10 |
| Age < 65 | 392 | 60 | 18.6 | 0.78 | 0.55–1.38 |
| Centre B | 270 | 92 | 35.0 | 0.96 | 0.59–1.23 |
| Control | 275 | 65 | 4.6 | 0.73 | 0.34–1.14 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.53 (95% CI 0.31 to 0.81). Serious adverse events were rare and similar between groups. acute kidney injury occurred in 14% of the intervention group versus 28% of controls.
The adjusted odds ratio was 0.83 (95% CI 0.20 to 0.61). The adjusted odds ratio was 0.39 (95% CI 0.35 to 0.97). Effects were consistent across prespecified subgroups.
Discussion
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
These findings suggest that frailty screening is associated with better acute kidney injury in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. These findings suggest that frailty screening is associated with better acute kidney injury in patients after cardiac surgery.
Future work should test frailty screening in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Future work should test frailty screening in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. These findings suggest that frailty screening is associated with better acute kidney injury in patients after cardiac surgery.
Conclusions
Frailty screening may be offered for patients after cardiac surgery to improve acute kidney injury.
Appendices
Ethics approval: IRB-7621.